BDA
Bod Australia
- Short interest
- 0.03%
- −0.15 pp 30d
- as of 25 Oct 2021
- Reported shorts
- 27K
- Shares on issue
- 105.824M
Bod Australia (BDA) company profile
Profile, insiders and operations
Company
AI-generated research profile of Bod Australia
Medicinal Cannabis
Health & Wellness
Pharmaceuticals
Biotechnology
ASX Listed
Bod Australia is an Australian-based company focused on the research, development, and commercialization of cannabis-derived products for therapeutic applications. The company aims to leverage scientific validation and product innovation to establish a strong position in the rapidly evolving medicinal cannabis and health & wellness markets. It typically offers a range of CBD and other cannabinoid-based products, often supported by clinical evidence, targeting both prescription and over-the-counter segments.
Director trades
No director trades found
BDA intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required